06/06/2018 Thought Leadership You know my brand name (look up the number) You know my BRAND name (look up the number) The FDA approved 46 novel therapies in 2017, a 21-year high and more than double the number approved during the previous...
22/05/2018 Thought Leadership Decluttering People Engagement Decluttering People Engagement Because engagement is broader than just the patient Earlier this year I was introduced to The KonMari Method™, developed by best selling author Marie Kondo. The method,...
04/05/2018 Thought Leadership On the credibility of the FDA’s breakthrough therapy designation On the credibility of the FDA’s breakthrough therapy designation It could be seen, perhaps, as a testament to the scientific endeavour powering the pharmaceutical industry that the FDA found it...
03/05/2018 Thought Leadership The answer is glaringly obvious: co-creation The answer is glaringly obvious: co-creation Part 3 of 3 of our “Right Patient, Right Drug, Wrong Place” series. Parts 1 & 2 of the “Right Person, Right Drug,...
27/04/2018 Thought Leadership Achieving world-class cancer outcomes by 2020 — how realistic is this? Achieving world-class cancer outcomes by 2020 — how realistic is this? Part 2 of our “Right Patient, Right Drug, Wrong Place” series Both the Møller and the Baldwin commentary, cited in Part...
23/04/2018 Thought Leadership The Future of Cancer Care in England The Future of Cancer Care in England Part 1 of our three part “Right Patient, Right Drug, Wrong Place” series Favourable lung cancer outcomes in England really are all about Location,...